Page last updated: 2024-09-05

anidulafungin and Candida Infection

anidulafungin has been researched along with Candida Infection in 166 studies

Research

Studies (166)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (1.20)	18.2507
2000's	70 (42.17)	29.6817
2010's	87 (52.41)	24.3611
2020's	7 (4.22)	2.80

Authors

Authors	Studies
Bocanegra, R; Graybill, JR; Molina, D; Najvar, LK; Olivo, M; Wiederhold, NP	1
Albert, N; Chamilos, G; Kontoyiannis, DP; Lewis, RE	1
Andes, D; Ashbeck, J; Diekema, DJ; Hou, J; Marchillo, K; Pfaller, MA; Prince, RA	1
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL	1
Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS	1
Jacobson, MJ; Nguyen, G; Patel, R; Piper, KE; Steckelberg, JM	1
Edlind, TD; Garcia-Effron, G; Katiyar, SK; Park, S; Perlin, DS	1
Damle, B; Dowell, J; Stogniew, M	1
Lewis, JS; Patterson, TF; Thompson, GR; Vallor, AC; Villareal, NC; Wiederhold, NP	1
Garcia-Effron, G; Grabinski, JL; Lee, SA; Perlin, DS; Wiederhold, NP	1
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS	1
Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N	1
Dimopoulos, G; Falagas, ME; Velegraki, A	1
Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, J; Sheehan, DJ	1
Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM	1
Guarro, J; Mariné, M; Pastor, FJ; Pontón, J; Quindós, G; Sahand, IH	1
Bonilla, H; Chua, DJ; DiPersio, J; Garcia-Effron, G; Ghannoum, M; Perlin, DS; Tomada, JR	1
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA; Woosley, LN	1
Andes, D; Bohrmuller, J; Diekema, DJ; Lepak, A; Marchillo, K; Pfaller, MA	1
Holtappels, M; Kucharíková, S; Lagrou, K; Tournu, H; Van Dijck, P	1
Bilal, H; Hou, B; Islam, R; Khan, MN; Khan, RU; Shafiq, M; Zeng, Y	1
Abastabar, M; Badiee, P; Haghani, I; Mohammadi, R; Morovati, H; Noorbakhsh, M; Sharifi, M	1
Brillowska-Dabrowska, A; Mroczyńska, M	1
Corcione, S; D'Avolio, A; De Rosa, FG; Pagani, N; Pasero, D; Sanguinetti, M; Trentalange, A	1
Bailey-Hytholt, CM; de Camargo Ribeiro, F; de Souza Santos, EL; Junqueira, JC; Langlois, L; Shukla, A; Vera-González, N	1
Alvarez, ME; Cuenca-Estrella, M; Fortun, J; Gioia, F; Gomez-García de la Pedrosa, E; Gomez-Lopez, A; Martín-Davila, P; Moreno, S	1
Bot, JCJ; de Leeuw, DC; Hendriks, EJ; Overgaauw, AJC; Stoof, SP; van Dijk, K	1
Chen, J; Chu, Y; Han, X; Shang, H; Tian, S; Wang, Q; Zhou, B	1
Brandão, IB; Colombo, AL; de Almeida, SLR; de Andrade, TS; de Miranda Costa, MM; de Oliveira Dias, P; de Souza Jordão, RT; Francisco, EC; Meis, JF; Nobrega de Almeida, J; Pereira, FM; Santos Ferreira, F	1
Aigner, M; Erbeznik, T; Gschwentner, M; Lass-Flörl, C	1
Cheung, YY; Hui, M	1
Bordallo-Cardona, MÁ; Bouza, E; Cantón, R; de la Pedrosa, EG; Díaz-García, J; Escribano, P; Guinea, J; Marcos-Zambrano, LJ	1
Iliopoulou-Kosmadaki, S; Kofteridis, DP; Kontakis, G; Koutserimpas, C; Samonis, G; Velivassakis, E	1
Bandini, G; Bellando Randone, S; Bernardi, P; Cioni, E; Finocchi, M; Gagliano, M; Marchiani, C; Moggi Pignone, A; Palagano, N	1
Holtappels, M; Kucharíková, S; Lagrou, K; Lamkanfi, M; Rogiers, O; Siala, W; Van Bambeke, F; Van Dijck, P	1
Clancy, CJ; Healey, KR; Kline, EG; Kordalewska, M; Nguyen, MH; Perlin, DS; Shields, RK	1
Almirante, B; Basas, J; Gavaldà, J; Gomis, X; Palau, M	1
Eraso, E; Gil-Alonso, S; Jauregizar, N; Quindós, G	1
Alvarez-Lerma, F; Barceló-Vidal, J; Campillo, N; González-Colominas, E; Grau, S; Hope, W; Horcajada, JP; Luque, S; Masclans, JR; Montero, M; Muñoz-Bermúdez, R; Sorli, L	1
Aram, JA; Capparella, MR; Montravers, P; Sganga, G; Tawadrous, M; Wang, M; Yan, JL	1
Arastehfar, A; Berman, J; Boekhout, T; Kostrzewa, M; Lass-Flörl, C; Sparbier, K; Vatanshenassan, M	1
Azanza Perea, JR; García-Montoto Pérez, F; Jerez Gómez-Coronado, V; Pazos Pacheco, C; Pérez Civantos, DV; Robles Marcos, M	1
Alberer, D; Fink, M; Grimm, G; Habernig, E; Kaulfersch, C; Preiss, P; Rab, A; Sternad-Klobschauer, K; Wandschneider, W; Zerlauth, U	1
Borghi, E; Cirasola, D; Morace, G; Ricucci, V; Sciota, R; Vizzini, L	1
Arendrup, MC; Bonfietti, LX; Bustamante, B; Canton, E; Chryssanthou, E; Cuenca-Estrella, M; Dannaoui, E; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gaustad, P; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Meis, JF; Moore, CB; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Pukinskas, SR; St-Germain, G; Szeszs, MW; Turnidge, J	1
Caggiano, G; Carocci, A; Carone, A; Carrieri, A; Catalano, A; Corbo, F; Franchini, C; Montagna, MT; Piarulli, M; Rosato, A; Schiavone, BP	1
Clancy, CJ; Nguyen, MH; Press, EG; Shields, RK; Updike, CL	1
Dimopoulou, D; Hamilos, G; Kontoyiannis, DP; Lewis, RE; Samonis, G; Tzardi, M	1
Alffenaar, JW; Arends, JP; Kosterink, JG; Rodgers, MG; Uges, DR; van der Werf, TS; van Wanrooy, MJ; Zijlstra, JG	1
Bustamante, B; Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Martin-Mazuelos, E; Meis, JF; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; St-Germain, G; Turnidge, J	1
Biswas, P; Chin-Hong, P; Kett, DH; Pappas, PG; Patterson, TF; Reboli, AC; Reinhardt, J; Swanson, R; Tobin, E; Vazquez, J	1
Bernardo, SM; Lee, SA; Walraven, CJ; Wiederhold, NP	1
Gil-Gómez, I; Lorente-Fernández, L; Monte-Boquet, E; Poveda-Andrés, JL; Ruiz-Ramos, J; Salavert-Lleti, M	1
Arendrup, MC; Jensen, RH; Justesen, US; Perlin, DS; Rewes, A	1
Baliellas, C; Bodro, M; Carratalà, J; Fabregat, J; Lladó, L; Petit, A; Ramos, E; Sabé, N; Solé, C	1
Cattel, F; Corcione, S; D'Avolio, A; De Rosa, FG; Di Perri, G; Motta, I	1
Balbino, S; Caggiano, G; Coretti, C; De Giglio, O; Iatta, R; Lovero, G; Martinelli, D; Montagna, MT; Rosato, A	1
Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA	1
Carbajal, WH; Lozada, C; Reyes, HA; Valdez, LM	1
Ghannoum, M; Katragkou, A; Petraitis, V; Roilides, E; Walsh, TJ	1
Katragkou, A; Roilides, E; Walsh, TJ	1
Perlin, DS	1
Álvarez-Escudero, J; Dominguez, D; Giménez, MJ; González-Serrano, M; Granizo, JJ; Maseda, E; Mouriz, L; Ojeda, N; Rodríguez-Manzaneque, M; Sánchez-Zamora, P	1
Caggiano, G; Carocci, A; Carone, A; Carrieri, A; Catalano, A; Corbo, F; Franchini, C; Montagna, MT; Rosato, A	1
Eraso, E; Gil-Alonso, S; Jauregizar, N; Ortega, I; Quindós, G; Suárez, E	1
Bouza, E; Escribano, P; Gómez-Perosanz, M; Guinea, J; Marcos-Zambrano, LJ; Zaragoza, O	1
Arslan, U; Dagi, HT; Findik, D; Senkeles, C	1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR	1
Cadirci, E; Duzgun, E; Karagoz, E; Keles, S; Turhan, V; Ugan, RA; Uyanik, MH; Yavan, I	1
Almirante, B; Basas, J; Del Pozo, JL; Gavaldà, J; Gomis, X; Martín, MT; Morer, A; Ratia, C; Rojo-Molinero, E; Torrents, E	1
Basso, M; Burastero, G; Carrega, G; Cavagnaro, L; Riccio, G; Ronca, A; Salomone, C	1
Balkovec, JM; Bartizal, K; Hough, G; James, KD; Krishnan, BR; Ong, V; Schlosser, M	1
Hsueh, PR; Wang, H; Xu, YC	1
Bouza, E; Escribano, P; Guinea, J; Marcos-Zambrano, LJ; Sánchez-Carrillo, C	1
Bordallo-Cardona, MÁ; Bouza, E; Cantón, R; de la Pedrosa, EG; Escribano, P; Guinea, J; Marcos-Zambrano, LJ	1
Barber, KE; Cretella, D; King, ST; Stover, KR	1
Ammenouche, N; Dupont, H; Jung, B; Massias, L; Montravers, P	1
Chang, CC; Chen, SC; Slavin, MA	1
Clark, K; Fichtenbaum, C; Goldstein, BP; Reboli, A; Schranz, JA; Vazquez, JA	1
Clemons, KV; Martinez, M; Stevens, DA; Tong, AJ; van Asbeck, E	1
Alexander, BD; Andes, D; Brown, SD; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Knapp, CC; Ostrosky-Zeichner, L; Pfaller, MA; Rex, JH; Sheehan, DJ; Walsh, TJ	1
Cubillos, GF; Kett, DH	1
de la Torre, P; Meyer, DK; Reboli, AC	1
Calis, KA; Estes, KE; Penzak, SR; Walsh, TJ	1
Baxa, D; Buhari, M; Chandra, J; Chen, A; Ghannoum, MA; Golembieski, A; Mukherjee, PK; Vazquez, JA	1
Cooper, C; Mills, EJ; Nachega, JB; Perri, D; Phillips, P; Tleyjeh, I; Wu, P	1
Cuenca-Estrella, M; Gurguí, M	1
Almirante, B; Pemán, J	1
Aguado, JM; Ayats, J	1
Borges Sá, M; Garnacho Montero, J	1
Ruiz Camps, I; Vázquez López, L	1
Balcer, HE; Chahine, EB; Sucher, AJ	1
Benner, KW; Prabhakaran, P; Varisco, BM	1
Viscoli, C	1
Gullo, A	1
Menichetti, F	1
De Bellis, P	1
Arendrup, MC; Cuenca-Estrella, M; Garcia-Effron, G; Lass-Flörl, C; Lopez, AG; Perlin, DS; Rodriguez-Tudela, JL	1
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S; Turnidge, J	1
Bal, AM	1
Dybas, L; El-Mortada, M; Havlichek, D; Prince, R; Smith, C; Stein, GE	1
Lanternier, F; Lortholary, O	1
Coote, PJ; Harris, MR	1
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA	1
Chandrasekar, PH; Cutright, JL; Krishnan-Natesan, S; Manavathu, EK	1
Diekema, D; Goldstein, BP; Henkel, T; Hollis, R; Messer, S; Pfaller, MA	1
Sganga, G	1
Venditti, M	1
Cervera, C; Escorsell, A; Linares, L; Moreno, A; Reverté, E	1
Accarpio, F; Di Giorgio, A; Falcone, M; Sammartino, P; Sibio, S; Vena, A; Venditti, M	1
Kuti, EL; Kuti, JL	1
Ahlquist, AM; Chiller, T; Farley, MM; Harrison, LH; Iqbal, N; Lockhart, SR; Zimbeck, AJ	1
Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S	1
Amorim, A; Costa-de-Oliveira, S; Gonçalves Rodrigues, A; Marcos Miranda, I; Pina-Vaz, C; Pinto E Silva, A; Rocha, R; Silva, RM	1
Andes, D; Arendrup, MC; Brown, SD; Diekema, DJ; Lockhart, SR; Motyl, M; Perlin, DS; Pfaller, MA	1
Cantón, E; Espinel-Ingroff, A	1
Arendrup, MC; Axner-Elings, M; Botero-Kleiven, S; Jensen, RH	1
Ahmad, S; Chandy, R; Joseph, L; Khan, Z; Theyyathel, A	1
George, J; Reboli, AC	1
Alastruey-Izquierdo, A; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Livermore, J; Perlin, DS; Sharp, A; Warn, PA	1
Calvo, E; Carrillo, AJ; Guarro, J; Mayayo, E; Pastor, FJ; Quindós, G; Salas, V	1
Bellmann, R; Gustorff, B; Hell, M; Illievich, U; Kratzer, C; Lass-Flörl, C; Moosbauer, W; Nachbaur, K; Perkhofer, S; Schwameis, F; Vogel, W; Von Goedecke, A; Wimmer, P; Zerlauth, U	1
Demitrovicova, A; Kisac, P; Krcmery, V	1
Benjamin, DK; Cohen-Wolkowiez, M; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, S; Livermore, J; Petraitiene, R; Petraitis, V; Sharp, A; Walsh, TJ; Warn, PA	1
Barchiesi, F; Giannini, D; Manso, E; Orlando, F; Posteraro, B; Sanguinetti, M; Spreghini, E	1
Fortún, J	1
Arendrup, MC; Goodwin, J; Hope, W; Howard, SJ; Jensen, RH; Perlin, DS	1
Baietto, L; Centofanti, P; Corcione, S; D'Avolio, A; De Rosa, FG; Di Perri, G; Pasero, D; Raviolo, S; Rinaldi, M	1
Abbott, J; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Livermore, JL; Sharp, A; Warn, PA	1
Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J	1
Dowell, JA; Henkel, T; Knebel, W; Krause, D; Ludden, T; Stogniew, M	1
Goldstein, BP; Henkel, T; Krause, DS; Reboli, A; Reinhardt, J; Vazquez, JA; Wible, M	1
Murdoch, D; Plosker, GL	1
Goldstein, BP; Henkel, T; Krause, DS; Simjee, AE; van Rensburg, C; Viljoen, J; Walsh, TJ; Wible, M	1
Darouiche, RO	1
Vazquez, JA	1
Boyken, L; Diekema, DJ; Goldstein, BP; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S	1
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S	1
Goldstein, BP; Hoban, DJ; Karlowsky, JA; Zhanel, GG	1
Burgess, DS; Carden, M; Cota, J; Graybill, JR; Najvar, LK; Wiederhold, NP	1
Deziel, MR; Drusano, GL; Drusano, MF; Gumbo, T; Liu, W; Louie, A; Ma, L	1
Bennett, JE	1
Morris, MI; Villmann, M	1
Graninger, W; Joukhadar, C; Presterl, E; Wagner, C	1
de la Torre, P; Reboli, AC	1
Cornely, OA; Karthaus, M; Kümmerle, T; Vehreschild, JJ	1
Betts, R; Chapman, SW; Goldstein, BP; Kett, DH; Krause, DS; Kumar, D; Pappas, PG; Reboli, AC; Rotstein, C; Schranz, J; Walsh, TJ; Wible, M	1
Revankar, SG; Sobel, JD	1
Khachikian, D; Kim, R; Reboli, AC	1
Aberegg, SK; O'Brien, JM	1
Moses, AE; Nir-Paz, R	1
Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S	1
Brielmaier, BD; Casabar, E; Kurtzeborn, CM; McKinnon, PS; Ritchie, DJ	1
Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Holliday, NM; Killian, SB; Knapp, CC; Messer, SA; Miskov, A; Pfaller, MA; Ramani, R	1
Del Palacio, A	1
Catalán González, M; León Gil, C; Montejo González, JC	1
Guarro, J; Pastor, FJ	1
Jamison, JA; LaGrandeur, LM; Rodriguez, MJ; Turner, WW; Zeckner, DJ	1
Bacher, J; Bell, A; Candelario, M; Groll, AH; Lyman, CA; McMillian, CL; Petraitiene, R; Petraitis, V; Sein, T; Walsh, TJ	1
Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL	1
Bacher, J; Francesconi, A; Groll, AH; Lyman, CA; Petraitiene, R; Petraitis, V; Piscitelli, SC; Schaufele, RL; Sein, T; Walsh, TJ	1
Denning, DW; Moore, CB; Oakley, KL	1
Bacher, JS; Groll, AH; Lyman, CA; Mickiene, D; Petraitiene, R; Petraitis, V; Piscitelli, SC; Walsh, TJ	1
Graybill, JR	1

Reviews

38 review(s) available for anidulafungin and Candida Infection

Article	Year
Distribution and antifungal susceptibility pattern of Virulence, 2022, Volume: 13, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests	2022
Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC infectious diseases, 2020, Nov-11, Volume: 20, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Micafungin; Prevalence	2020
Candida glabrata prosthetic joint infection, successfully treated with anidulafungin: A case report and review of the literature. Mycoses, 2018, Volume: 61, Issue:4 Topics: Aged; Alcoholism; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Arthritis; Candida glabrata; Candidiasis; Echinocandins; Female; Humans; Knee Joint; Prosthesis-Related Infections; Pulmonary Disease, Chronic Obstructive; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin	2018
A rare case of Candida glabrata spondylodiscitis: case report and literature review. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 68 Topics: Abscess; Aged; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Debridement; Discitis; Drug Resistance, Fungal; Echinocandins; Humans; Immunosuppression Therapy; Lumbar Vertebrae; Male	2018
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. Le infezioni in medicina, 2014, Volume: 22, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Europe; Fluconazole; Guidelines as Topic; Humans; Italy; Randomized Controlled Trials as Topic; Treatment Outcome; United States	2014
Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Catheter-Related Infections; Disease Models, Animal; Echinocandins; Fungi; Humans; Immunomodulation; Microbial Sensitivity Tests; Mucous Membrane; Mycoses	2015
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future microbiology, 2016, Volume: 11 Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole	2016
New developments and directions in the clinical application of the echinocandins. Archives of toxicology, 2017, Volume: 91, Issue:4 Topics: Administration, Intravenous; Anidulafungin; Animals; Antifungal Agents; Biofilms; Candidiasis; Caspofungin; Drug Administration Schedule; Drug Interactions; Echinocandins; Humans; Lipopeptides; Micafungin	2017
Anidulafungin in the treatment of patients with invasive candidiasis. International journal of antimicrobial agents, 2008, Volume: 32 Suppl 2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole	2008
Anidulafungin: a novel echinocandin for candida infections. Future microbiology, 2008, Volume: 3, Issue:6 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Injections, Intravenous; Microbial Viability; United States	2008
Pharmacology and antifungal properties of anidulafungin, a new echinocandin. Pharmacotherapy, 2009, Volume: 29, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Drug Costs; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Esophageal Diseases; Humans	2009
Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis. Annals of clinical microbiology and antimicrobials, 2009, Jun-26, Volume: 8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis; Echinocandins; Fluconazole; Humans; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult	2009
[Current status of invasive fungal infections. New diagnostic techniques and antifungal agents]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; beta-Glucans; Candidiasis; Clinical Trials as Topic; Critical Care; Diabetes Complications; Disease Susceptibility; Echinocandins; Fungemia; Galactose; Hematologic Diseases; Humans; Immunocompromised Host; Mannans; Meta-Analysis as Topic; Mycoses; Neoplasms; Opportunistic Infections	2008
[Current treatment of candidemia. Role of anidulafungin]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Double-Blind Method; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungemia; Gastrointestinal Diseases; Global Health; Humans; Middle Aged; Multicenter Studies as Topic; Neutropenia; Risk Factors; Species Specificity	2008
[Role of anidulafungin in solid organ transplant recipients]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Interactions; Echinocandins; Fungemia; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Organ Transplantation; Postoperative Complications; Premedication; Risk Factors	2008
[Role of anidulafungin in critically ill patients]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Illness; Cross Infection; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungemia; Humans; Immunocompetence; Intensive Care Units; Itraconazole; Practice Guidelines as Topic	2008
[Potential of anidulafungin in hematological patients]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Azoles; Candidiasis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echinocandins; Fungemia; Hematologic Diseases; Hematologic Neoplasms; Humans; Inactivation, Metabolic; Kidney Diseases; Liver Diseases; Mice; Neutropenia; Risk Factors	2008
Echinocandins: the newest class of antifungals. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses	2009
Invasive fungal infections: the challenge continues. Drugs, 2009, Volume: 69 Suppl 1 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candida; Candidiasis; Drug Therapy, Combination; Echinocandins; Humans; Mycoses; Risk Factors	2009
Anidulafungin, a new echinocandin: effectiveness and tolerability. Drugs, 2009, Volume: 69 Suppl 1 Topics: Anidulafungin; Animals; Antifungal Agents; Candidiasis; Echinocandins; Humans; Mycoses	2009
The echinocandins: three useful choices or three too many? International journal of antimicrobial agents, 2010, Volume: 35, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Clinical Trials as Topic; Echinocandins; Humans; Lipopeptides; Micafungin	2010
[Anidulafungin: a new therapeutic option in systemic candidiasis]. Medecine et maladies infectieuses, 2010, Volume: 40, Issue:8 Topics: Anidulafungin; Animals; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Echinocandins; Humans	2010
Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections. Expert opinion on drug metabolism & toxicology, 2010, Volume: 6, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Mycoses	2010
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2011, Volume: 14, Issue:3 Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Proteoglycans; Randomized Controlled Trials as Topic; Species Specificity; Treatment Outcome	2011
In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same? Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2 Topics: Anidulafungin; Candida; Candidiasis; Caspofungin; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Glucosyltransferases; Humans; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity; Therapeutic Equivalency	2011
Anidulafungin: when and how? The clinician's view. Mycoses, 2012, Volume: 55, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
[Antifungal therapy update: new drugs and medical uses]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 5 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles	2011
Anidulafungin: ECB, LY 303366, V-echinocandin, VEC, VER 002, VER-02. Drugs in R&D, 2003, Volume: 4, Issue:3 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Drugs, Investigational; Echinocandins; Humans; Peptides, Cyclic; Saccharomyces cerevisiae	2003
Anidulafungin: a new echinocandin with a novel profile. Clinical therapeutics, 2005, Volume: 27, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida; Candidiasis; Echinocandins; Humans; Microbial Sensitivity Tests; Peptides, Cyclic	2005
Echinocandins for candidemia in adults without neutropenia. The New England journal of medicine, 2006, Sep-14, Volume: 355, Issue:11 Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fungemia; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Peptides, Cyclic; Practice Guidelines as Topic	2006
Echinocandins in the management of invasive fungal infections, Part 2. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Oct-01, Volume: 63, Issue:19 Topics: Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Catheterization; Critical Care; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Transplants	2006
The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology, 2006, Volume: 78, Issue:4 Topics: Actins; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Lipopeptides; Lipoproteins; Liver; Liver Failure; Micafungin; Models, Chemical; Peptides, Cyclic; Rats	2006
Anidulafungin: a new echinocandin for candidal infections. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:1 Topics: Anidulafungin; Animals; Candidiasis; Drugs, Investigational; Echinocandins; Fungal Proteins; Humans; Peptides, Cyclic	2007
Anidulafungin--state of affairs from a clinical perspective. Mycoses, 2007, Volume: 50 Suppl 1 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Drug Interactions; Echinocandins; Humans; Rabbits	2007
A comparative evaluation of properties and clinical efficacy of the echinocandins. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Enzyme Inhibitors; Glucosyltransferases; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Treatment Outcome	2007
[Anidulafungin: a new echinocandin for the treatment of mycosis]. Revista iberoamericana de micologia, 2008, Volume: 25, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candidiasis; Echinocandins; Humans	2008
[Therapeutic efficacy of anidulafungin for the treatment of oesophageal candidiasis, candidemia and invasive candidiasis]. Revista iberoamericana de micologia, 2008, Volume: 25, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candidiasis; Echinocandins; Esophagitis; Fungemia; Humans	2008
[Anidulafungin: experimental therapy of fungal infections in animal models]. Revista iberoamericana de micologia, 2008, Volume: 25, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Echinocandins; Lung Diseases, Fungal	2008

Trials

7 trial(s) available for anidulafungin and Candida Infection

Article	Year
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial. BMC infectious diseases, 2014, Feb-21, Volume: 14 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Candidiasis, Invasive; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Republic of Korea; Research Design; Risk; Treatment Outcome; United States; Voriconazole; Young Adult	2014
A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis. Journal of acquired immune deficiency syndromes (1999), 2008, Jul-01, Volume: 48, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Azoles; Candidiasis; Candidiasis, Oral; Drug Resistance, Fungal; Echinocandins; Esophageal Diseases; Female; Humans; Male; Middle Aged; Mucous Membrane	2008
Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal. Journal of clinical pharmacology, 2004, Volume: 44, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Echinocandins; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Monte Carlo Method; Peptides, Cyclic; Racial Groups; Sex Factors	2004
Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; APACHE; Candidiasis; Dose-Response Relationship, Drug; Echinocandins; Female; Fungemia; Humans; Male; Middle Aged; Peptides, Cyclic; Prospective Studies	2004
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6 Topics: Administration, Oral; Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Double-Blind Method; Echinocandins; Esophageal Diseases; Female; Fluconazole; Humans; Infusions, Intravenous; Male; Middle Aged; Peptides, Cyclic	2004
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:11 Topics: Adult; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Humans; Microbial Sensitivity Tests; Peptides, Cyclic	2005
Anidulafungin versus fluconazole for invasive candidiasis. The New England journal of medicine, 2007, Jun-14, Volume: 356, Issue:24 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Double-Blind Method; Echinocandins; Female; Fluconazole; Fungemia; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Peptides, Cyclic; Treatment Outcome	2007

Other Studies

121 other study(ies) available for anidulafungin and Candida Infection

Article	Year
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peptides, Cyclic; Serum	2007
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fungemia; Humans; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Species Specificity	2007
In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida; Candidiasis; Disease Models, Animal; Echinocandins; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Treatment Outcome	2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity	2008
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation	2008
In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests	2008
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Enzyme Inhibitors; Fungal Proteins; Gene Expression; Genes, Fungal; Glucosyltransferases; Humans; Membrane Proteins; Molecular Sequence Data; Mutagenesis, Site-Directed; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Species Specificity	2008
Pharmacokinetics and tissue distribution of anidulafungin in rats. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Anidulafungin; Animals; Antifungal Agents; Autoradiography; Candidiasis; Carbon Radioisotopes; Echinocandins; Humans; Infusions, Intravenous; Kidney; Liver; Lung; Male; Rats; Rats, Inbred F344; Spleen; Tissue Distribution	2008
Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Adult; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida glabrata; Candidiasis; Caspofungin; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Lipopeptides	2008
Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Anidulafungin; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; DNA Mutational Analysis; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Point Mutation	2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged	2008
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction	2009
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies	2009
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Echinocandins; Kidney; Male; Mice	2009
Anidulafungin treatment of candidal central nervous system infection in a murine model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole	2009
Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Male; Micafungin; Mice	2009
Novel FKS mutations associated with echinocandin resistance in Candida species. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Adult; Antifungal Agents; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Glucosyltransferases; Humans; Male; Middle Aged; Mutation	2010
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida; Candida albicans; Candida glabrata; Candidiasis; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Homology, Amino Acid; Species Specificity	2010
In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Female; Kidney; Lipopeptides; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Protein Binding; Species Specificity	2010
In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Catheters; Echinocandins; Female; Rats; Rats, Sprague-Dawley	2010
A 3-year study of Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Neoplasms	2023
First report on echinocandin resistant Polish Candida isolates. Acta biochimica Polonica, 2019, Sep-12, Volume: 66, Issue:3 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Micafungin; Microbial Sensitivity Tests; Poland	2019
Acquisition of FKS2 mutation after echinocandin treatment of infective endocarditis by Candida glabrata. Le infezioni in medicina, 2019, Sep-01, Volume: 27, Issue:3 Topics: Aged; Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Candidiasis; Endocarditis; Female; Fungal Proteins; Heart Valve Prosthesis Implantation; Humans; Microbial Sensitivity Tests; Point Mutation; Voriconazole	2019
Anidulafungin liposome nanoparticles exhibit antifungal activity against planktonic and biofilm Candida albicans. Journal of biomedical materials research. Part A, 2020, 11-01, Volume: 108, Issue:11 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Humans; Liposomes; Nanoparticles; Plankton	2020
Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 101 Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Critical Illness; Echinocandins; Female; Humans; Male; Micafungin; Microbial Sensitivity Tests; Peritonitis; Prospective Studies	2020
Case report: Candida krusei spondylitis in an immunocompromised patient. BMC infectious diseases, 2020, Oct-08, Volume: 20, Issue:1 Topics: Aged; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Humans; Immunocompromised Host; Induction Chemotherapy; Male; Micafungin; Spondylitis; Treatment Outcome; Voriconazole	2020
Axillary Digital Thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil. Mycoses, 2021, Volume: 64, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Brazil; Candida; Candidiasis; COVID-19; Critical Care; Disease Outbreaks; Disease Transmission, Infectious; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; SARS-CoV-2; Thermometers; Voriconazole	2021
Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Anidulafungin; Antifungal Agents; Austria; Candida; Candidiasis; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin	2017
Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Aminoglycosides; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Chitin Synthase; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests	2017
Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata. Medical mycology, 2018, Oct-01, Volume: 56, Issue:7 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Disease Models, Animal; DNA Mutational Analysis; Drug Resistance, Fungal; Glucosyltransferases; Lepidoptera; Micafungin; Mutation; Survival Analysis	2018
Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies. The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10 Topics: Anidulafungin; Animals; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Coinfection; Disease Models, Animal; Drug Synergism; Flow Cytometry; Foreign Bodies; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Treatment Outcome	2018
Spontaneous Mutational Frequency and Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Genetic Loci; Glucosyltransferases; Humans; Micafungin; Microbial Sensitivity Tests; Mutation Rate	2019
Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model. PloS one, 2019, Volume: 14, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candida albicans; Candida glabrata; Candidiasis; Catheter-Related Infections; Catheters; Models, Theoretical; Rabbits	2019
Postantifungal effect of anidulafungin against Candida albicans, Candida dubliniensis, Candida africana, Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Time Factors	2019
Population Pharmacokinetics of Anidulafungin in Critically Ill Patients. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Body Weight; Candida albicans; Candida glabrata; Candidiasis; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological	2019
Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:10 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Intraabdominal Infections; Male; Middle Aged; Prospective Studies; Surgical Wound Infection; Treatment Outcome; Young Adult	2019
Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9 Topics: Anidulafungin; Antifungal Agents; Blood Culture; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Glucosyltransferases; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2019
Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 86 Topics: Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; APACHE; Area Under Curve; Ascitic Fluid; Candida; Candidiasis; Critical Illness; Echinocandins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Prospective Studies	2019
A severe case of haemodynamic instability during anidulafungin administration. Journal of clinical pharmacy and therapeutics, 2013, Volume: 38, Issue:3 Topics: Adult; Anidulafungin; Antifungal Agents; Bradycardia; Candida glabrata; Candidiasis; Echinocandins; Hemodynamics; Humans; Hypotension; Male	2013
Experimental biofilm-related Candida infections. Future microbiology, 2013, Volume: 8, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Disease Models, Animal; Echinocandins; Larva; Lepidoptera; Survival Analysis; Treatment Outcome	2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Europe; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; North America; Observer Variation; South America; Species Specificity	2013
In vitro effectiveness of anidulafungin against Candida sp. biofilms. The Journal of antibiotics, 2013, Volume: 66, Issue:12 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Candida tropicalis; Candidiasis; Catheter-Related Infections; Echinocandins; Humans; Microbial Sensitivity Tests; Species Specificity	2013
Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2013
Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C	2014
Low but sufficient anidulafungin exposure in critically ill patients. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1 Topics: Aged; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Critical Illness; Echinocandins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged	2014
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Europe; Fungal Proteins; Gene Expression; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; North America; South America	2014
Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. Medical mycology, 2014, Volume: 52, Issue:2 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron; Mutant Proteins; Staining and Labeling	2014
Anidulafungin-induced alopecia. The Annals of pharmacotherapy, 2014, Volume: 48, Issue:5 Topics: Adult; Alopecia; Anidulafungin; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Micafungin	2014
Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Amino Acid Substitution; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Cerebral Infarction; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Glucosyltransferases; Humans; Lymphoma, Large B-Cell, Diffuse; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Sequence Analysis, DNA; Species Specificity; Treatment Failure	2014
Candida arteritis occurring in a liver transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:3 Topics: Anidulafungin; Antifungal Agents; Arteritis; Candidiasis; Echinocandins; Fatal Outcome; Graft Rejection; Humans; Liver Transplantation; Male; Middle Aged; Voriconazole	2014
Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. BMC microbiology, 2015, May-20, Volume: 15 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Hospitals, University; Humans; Italy; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2015
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution. BMC infectious diseases, 2015, Jul-03, Volume: 15 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole	2015
Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient. BMJ case reports, 2015, Oct-09, Volume: 2015 Topics: Adult; Anidulafungin; Antifungal Agents; Aorta; Candida; Candidiasis; Cross Infection; Echinocandins; Echocardiography; Endocarditis; Female; Humans; Immunocompromised Host; Ovarian Neoplasms; Voriconazole	2015
The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices	2015
Echinocandin Resistance in Candida. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Antifungal Agents; Azoles; Candida; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Glucosyltransferases; Humans; Intraabdominal Infections; Lipopeptides; Micafungin; Mutation	2015
Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: A multicenter retrospective study. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:1 Topics: Abdomen; Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Critical Care; Echinocandins; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Peritonitis; Retrospective Studies; Shock, Septic; Spain; Treatment Outcome	2016
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp. Bioorganic & medicinal chemistry, 2016, Mar-01, Volume: 24, Issue:5 Topics: Anidulafungin; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Aspirin; Biofilms; Candida; Candidiasis; Drug Synergism; Echinocandins; Humans	2016
In vitro pharmacodynamic modelling of anidulafungin against Candida spp. International journal of antimicrobial agents, 2016, Volume: 47, Issue:3 Topics: Anidulafungin; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Echinocandins; Humans; Microbial Sensitivity Tests; Models, Statistical	2016
Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2016
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Annals of clinical microbiology and antimicrobials, 2016, May-31, Volume: 15, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole	2016
Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Candida; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Half-Life; Humans; Lipopeptides; Microbial Sensitivity Tests	2016
A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model. Current eye research, 2017, Volume: 42, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Intravitreal Injections; Iris; Male; Rabbits; Vitreous Body; Voriconazole	2017
Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Catheter-Related Infections; Catheters, Indwelling; Echinocandins; Male; Microbial Sensitivity Tests; Rabbits; Silicones	2016
Azole-resistant Candida albicans prosthetic joint infection treated with prolonged administration of anidulafungin and two-stage exchange with implant of a mega-prosthesis. Journal of chemotherapy (Florence, Italy), 2017, Volume: 29, Issue:6 Topics: Aged; Anidulafungin; Antifungal Agents; Arthroplasty, Replacement, Hip; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Humans; Prosthesis-Related Infections; Reoperation	2017
Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Biotransformation; Blood Proteins; Candidiasis; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Echinocandins; Female; Humans; Inactivation, Metabolic; Macaca fascicularis; Male; Microbial Sensitivity Tests; Microsomes, Liver; Rats, Sprague-Dawley	2016
Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candida tropicalis; Candidemia; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2017
In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation	2017
Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp. Journal of medical microbiology, 2016, Volume: 65, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Respiratory System; Urine	2016
Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis. The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Administration, Intravenous; Aged; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Chromatography, High Pressure Liquid; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Intraabdominal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies	2017
Significant differences in drug susceptibility among species in the Candida parapsilosis group. Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique	2008
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. Journal of clinical microbiology, 2008, Volume: 46, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Statistics as Topic; Treatment Outcome	2008
Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15, Issue:3 Topics: Anidulafungin; Antifungal Agents; Burn Units; Burns; Candida; Candidiasis; Carrier State; Caspofungin; Echinocandins; Environmental Microbiology; Fungal Proteins; Genotype; Glucosyltransferases; Health Personnel; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Sequence Analysis, DNA	2009
Neonatal peritoneal candidiasis successfully treated with anidulafungin add-on therapy. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:11 Topics: Amphotericin B; Anidulafungin; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Humans; Infant, Newborn; Peritoneal Cavity; Treatment Outcome	2009
Recent advances in the management of invasive candidiasis: role of anidulafungin. Drugs, 2009, Volume: 69 Suppl 1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Humans	2009
Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections. Drugs, 2009, Volume: 69 Suppl 1 Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candidiasis; Cross Infection; Echinocandins; Humans	2009
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Culture Media; Echinocandins; Indicator Dilution Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Reference Standards	2010
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. Journal of clinical microbiology, 2010, Volume: 48, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2010
Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Echinocandins; Female; Fungemia; Humans; Male; Microbial Viability; Middle Aged; Serum; Young Adult	2010
Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. International journal of antimicrobial agents, 2010, Volume: 35, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Antimicrobial Cationic Peptides; Body Weight; Candida albicans; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Humans; Kidney; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability	2010
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. Journal of clinical microbiology, 2010, Volume: 48, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2010
Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Female; Fluconazole; Humans; Immunocompromised Host; Kidney; Lipopeptides; Mice; Mice, Inbred ICR; Neutropenia; Spleen; Treatment Outcome	2010
In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trial. Journal of clinical microbiology, 2010, Volume: 48, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Resistance, Fungal; Echinocandins; Esophageal Diseases; Humans; Microbial Sensitivity Tests	2010
Case report 4: Elderly patient with concomitant conditions. Mycoses, 2010, Volume: 53 Suppl 2 Topics: Aged; Anidulafungin; Antifungal Agents; Bacteremia; Candida; Candidiasis; Echinocandins; Enterococcus faecalis; Female; Fungemia; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Peritonitis; Radiography, Abdominal; Tomography, X-Ray Computed	2010
Case report 5: Intensive care unit patient assessed using the Candida Score. Mycoses, 2010, Volume: 53 Suppl 2 Topics: Accidents, Traffic; Adult; Anidulafungin; Antifungal Agents; Candida albicans; Candidiasis; Echinocandins; Fluconazole; Humans; Intensive Care Units; Male; Postoperative Complications; Severity of Illness Index; Treatment Outcome	2010
Case report 6: Candidaemia in a high risk liver transplant recipient. Mycoses, 2010, Volume: 53 Suppl 2 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Bronchitis; Candida albicans; Candidiasis; Echinocandins; Female; Fluconazole; Fungemia; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Liver Failure; Liver Transplantation; Postoperative Complications; Stenotrophomonas maltophilia; Transplantation; Treatment Outcome; Young Adult	2010
Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:10 Topics: Aged; Anidulafungin; Antifungal Agents; Candidiasis; Carcinoma; Echinocandins; Female; Humans; Lung Diseases, Fungal; Middle Aged; Peritoneal Neoplasms; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome	2010
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction	2010
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin. Journal of clinical microbiology, 2011, Volume: 49, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3 Topics: Aged; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Glucosyltransferases; Humans; Mutation	2011
Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden. Journal of clinical microbiology, 2011, Volume: 49, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation, Missense; Sweden	2011
Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Retrospective Studies	2011
Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Neutropenia	2011
Anidulafungin in treatment of experimental invasive infection by Candida parapsilosis: in vitro activity, (1-->3)-beta-D-glucan and mannan serum levels, histopathological findings, and in vivo efficacy. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11 Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Echinocandins; Kaplan-Meier Estimate; Male; Mannans; Mice; Microbial Sensitivity Tests	2011
Austrian clinical practice with anidulafungin in 2008: a multicenter survey. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Anidulafungin; Antifungal Agents; Austria; Candida; Candidemia; Candidiasis; Candidiasis, Invasive; Comorbidity; Echinocandins; Female; Humans; Male; Medical Records; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors	2011
Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Slovakia; Treatment Outcome; Triazoles	2011
Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Disease Models, Animal; Echinocandins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Meningitis, Fungal; Meningoencephalitis; Monte Carlo Method; Rabbits; Treatment Outcome	2012
Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Lipopeptides; Micafungin; Mice; Microbial Sensitivity Tests; Mutation	2012
Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Biological Availability; Candida glabrata; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Kidney; Lipopeptides; Micafungin; Mice; Microbial Sensitivity Tests; Mutation	2012
Anidulafungin for Candida glabrata infective endocarditis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8 Topics: Aged; Anemia, Hemolytic, Autoimmune; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Echinocandins; Endocarditis; Female; Hepatitis C; Humans; Liver Cirrhosis; Pancytopenia; Thrombocytopenia; Tricuspid Valve	2012
Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Dosage Calculations; Echinocandins; Endophthalmitis; Kidney; Male; Models, Biological; Rabbits; Vitreous Body	2013
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001). Diagnostic microbiology and infectious disease, 2003, Volume: 46, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole	2003
Anidulafungin. Drugs, 2004, Volume: 64, Issue:19 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cell Wall; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation, Preclinical; Echinocandins; Esophageal Diseases; Glucosyltransferases; Humans; Infusions, Intravenous; Injections, Intravenous; Molecular Structure; New Zealand; Peptides, Cyclic; Time Factors; Treatment Outcome	2004
Echinocandins: ask not what they can do for esophageal candidiasis--ask what studies of esophageal candidiasis can do for them. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Esophageal Diseases; Fungal Proteins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic	2004
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. Journal of clinical microbiology, 2005, Volume: 43, Issue:11 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Peptides, Cyclic	2005
In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species. International journal of antimicrobial agents, 2006, Volume: 27, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Interactions; Echinocandins; Flucytosine; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Peptides, Cyclic	2006
Anidulafungin (Eraxis) for Candida infections. The Medical letter on drugs and therapeutics, 2006, May-22, Volume: 48, Issue:1235 Topics: Anidulafungin; Animals; Antifungal Agents; Candidiasis; Drug Interactions; Echinocandins; Half-Life; Humans; Peptides, Cyclic; Randomized Controlled Trials as Topic	2006
In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colorimetry; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Tetrazolium Salts	2006
Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11 Topics: Algorithms; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida glabrata; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Echinocandins; Female; Fluconazole; Mice; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic	2006
Echinocandins--first-choice or first-line therapy for invasive candidiasis? The New England journal of medicine, 2007, Jun-14, Volume: 356, Issue:24 Topics: Anidulafungin; Antifungal Agents; Candidiasis; Echinocandins; Fluconazole; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Peptides, Cyclic	2007
Anidulafungin and fluconazole for candidiasis. The New England journal of medicine, 2007, Sep-27, Volume: 357, Issue:13 Topics: Anidulafungin; Antifungal Agents; Candidiasis; Confidence Intervals; Echinocandins; Fluconazole; Humans; Peptides, Cyclic; Research Design	2007
Anidulafungin and fluconazole for candidiasis. The New England journal of medicine, 2007, Sep-27, Volume: 357, Issue:13 Topics: Administration, Oral; Analysis of Variance; Anidulafungin; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Peptides, Cyclic; Time Factors	2007
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. Journal of clinical microbiology, 2008, Volume: 46, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests	2008
Early clinical experience with anidulafungin at a large tertiary care medical center. Pharmacotherapy, 2008, Volume: 28, Issue:1 Topics: Academic Medical Centers; Alanine Transaminase; Anidulafungin; Antifungal Agents; Aspartate Aminotransferases; Back Pain; Candida; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Humans; Male; Metronidazole; Missouri; Mycoses; Retrospective Studies; Time Factors; Treatment Outcome	2008
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. Journal of clinical microbiology, 2008, Volume: 46, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Reference Standards; Reproducibility of Results; Sensitivity and Specificity	2008
The synthesis and antifungal activity of nitrogen containing hemiaminal ethers of LY303366. The Journal of antibiotics, 1998, Volume: 51, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; Candidiasis; Echinocandins; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peptides, Cyclic; Structure-Activity Relationship	1998
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:9 Topics: Amphotericin B; Analysis of Variance; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Dose-Response Relationship, Drug; Echinocandins; Female; Fluconazole; Metabolic Clearance Rate; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic; Potassium; Rabbits	1999
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Echinocandins; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic	2000
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Resistance, Microbial; Echinocandins; Esophageal Diseases; Esophagus; Female; Fluconazole; Immunosuppression Therapy; Peptides, Cyclic; Pharyngeal Diseases; Rabbits; Saliva	2001
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Culture Media; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Reproducibility of Results	2001
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Echinocandins; Female; Lung Diseases, Fungal; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Rabbits; Tissue Distribution	2001
The echinocandins, first novel class of antifungals in two decades: will they live up to their promise? International journal of clinical practice, 2001, Volume: 55, Issue:9 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cell Wall; Echinocandins; Fungi; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides; Peptides, Cyclic; Randomized Controlled Trials as Topic	2001